Short communication · 29 Aug 2025
EditorialPublished 20 May 2022
Note on Antibody Drug Conjugates
Keywords
Subjects
Pharmaceutical SciencesSimilar by topic
Short communication · 28 Feb 2025
Challenges and Innovations in the Clinical Application of Antibody-drug Conjugates
Perspective · 26 Dec 2023
Harnessing the Power of Antibodies and Antibody-Drug Conjugates: A Revolution in Targeted Therapies
Perspective · 29 Jun 2023
The Role of Antibody-Drug Conjugates in Immuno-Oncology: Combination Approaches for Improved Responses
Mini review · 30 May 2023
Technology Considerations for production of Antibodies and Antibody-Drug Conjugates in Cancer Therapy
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Tefera Bourin”

